PT-141 (10mg)

$99.99

Buy PT-141 10mg in Australia from Aussie Peptide — $99.99 AUD, with fast, discreet domestic dispatch and same business day shipping on orders placed before 12:00pm AEST/AEDT. This lyophilised powder is independently verified to ≥99% purity by HPLC and mass spectrometry, with a batch-specific Certificate of Analysis (CoA) supplied for every order placed. PT-141 is classified as a Synthetic melanocortin receptor agonist, and is also searched online as PT141 peptide, Bremelanotide research analogue, with research interest centred on mc3r/mc4r receptor subtype studies. All stock is held locally in our Australian warehouse, so researchers avoid the customs delays, seizure risk, and import uncertainty associated with overseas suppliers. PT-141 is supplied strictly for in-vitro laboratory research use only — it is not a drug, food supplement, or cosmetic, and is not approved for human or veterinary use. Explore the full Melanocortin Agonists range for related compounds, or review verified results in the CoA Library before you order. Must be 18+ to purchase.

SKU: PEP-035-10MG Category:

Buy PT-141 10mg in Australia | Aussie Peptide

Aussie Peptide supplies PT-141 10mg to Australian research laboratories, independently verified
to ≥99% purity by HPLC and mass spectrometry, with a Certificate of Analysis issued for every batch.
Stock is held domestically, meaning researchers ordering PT-141 in Australia avoid the customs
delays and import uncertainty associated with overseas suppliers.

What Is PT-141?

PT-141 is a synthetic peptide analogue of α-MSH studied for its activity at melanocortin 3 and 4 receptor subtypes, distinguishing its research profile from pigmentation-focused melanocortin agonists. PT-141 is also referenced under several alternate names in research
literature and online research communities, including PT141 peptide, Bremelanotide research analogue — all describing the same
Synthetic melanocortin receptor agonist listed on this page.

PT-141 Research Applications

Laboratories purchasing PT-141 10mg from Aussie Peptide are typically investigating one or more
of the following research areas:

  • MC3R/MC4R receptor subtype studies
  • Central nervous system melanocortin signalling research
  • Comparative melanocortin agonist selectivity studies
  • Hypothalamic pathway modelling

For comparative research, see Melanotan II (10mg).

PT-141 Purity, Testing & Certificates of Analysis

Every batch of PT-141 sold by Aussie Peptide is tested by an accredited third-party laboratory using
HPLC and mass spectrometry to confirm ≥99% purity before release. The batch-specific Certificate of
Analysis for this product is available in our CoA Library, allowing
researchers to verify identity and purity prior to ordering.

PT-141 Specifications

Compound PT-141
Classification Synthetic melanocortin receptor agonist
Pack Size 10mg
SKU PEP-035-10MG
Purity ≥99% (HPLC & Mass Spectrometry verified)
Form Lyophilised powder
Stock Status Pre-Order
Price (AUD) $99.99
Intended Use In-vitro laboratory research only — not for human or veterinary use
Country of Supply Australia

Buying PT-141 in Australia

Aussie Peptide dispatches PT-141 10mg from an Australian warehouse, with same business day
dispatch available on orders placed before 12:00pm AEST/AEDT. Researchers can browse the complete
Melanocortin Agonists category for related compounds,
or visit the main Shop page to view all 45+ compounds currently in stock.
PT-141 is supplied strictly for in-vitro laboratory research and is not approved for human or
veterinary use. Purchasers must be 18 years or older.

Frequently Asked Questions

What is PT-141?

PT-141 is a Synthetic melanocortin receptor agonist. PT-141 is a synthetic peptide analogue of α-MSH studied for its activity at melanocortin 3 and 4 receptor subtypes, distinguishing its research profile from pigmentation-focused melanocortin agonists.

What is PT-141 also known as?

In research literature and online research communities, PT-141 is also searched as PT141 peptide, Bremelanotide research analogue. All of these refer to the same compound listed on this page.

Where can I buy PT-141 10mg in Australia?

You can buy PT-141 10mg directly from Aussie Peptide, with stock held in our Australian warehouse and dispatched domestically — no international shipping delays. For comparative research, see Melanotan II (10mg).

What is the cost of PT-141 10mg in Australia?

PT-141 10mg is priced at $99.99 AUD on this page. Pricing reflects independently verified ≥99% purity and includes a Certificate of Analysis for the batch.

Can I buy PT-141 at a chemist or compounding pharmacy in Australia?

No. PT-141 is not stocked by retail chemists such as Chemist Warehouse, and Australian compounding pharmacies do not supply it for personal use. Aussie Peptide supplies PT-141 exclusively for in-vitro laboratory research, not for compounding into a human-use product.

What does current research show about PT-141?

Current preclinical literature on PT-141 focuses on mc3r/mc4r receptor subtype studies and central nervous system melanocortin signalling research. Researchers should consult the CoA Library and current peer-reviewed literature for batch-specific and study-specific detail.

How should PT-141 be reconstituted for laboratory use?

Researchers typically reconstitute lyophilised PT-141 using bacteriostatic water (see our BAC Water page) under sterile laboratory conditions. Always follow your institution’s standard reconstitution protocol.

How should PT-141 be stored?

Lyophilised PT-141 should be stored in a freezer (-20°C) prior to reconstitution for long-term stability, and refrigerated (2-8°C) once reconstituted. Avoid repeated freeze-thaw cycles, which can degrade peptide integrity.

How do I order PT-141 online in Australia?

Add PT-141 10mg to your cart on this page and complete checkout via PayID or bank transfer. Orders from our Australian warehouse are dispatched same business day when placed before 12:00pm AEST/AEDT.

Reviews

There are no reviews yet.

Be the first to review “PT-141 (10mg)”

Your email address will not be published. Required fields are marked *